These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain. Mjörndal T; Winblad B Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030 [TBL] [Abstract][Full Text] [Related]
13. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. Seeman P; Niznik HB FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154 [TBL] [Abstract][Full Text] [Related]
14. Utilization of radioligands in schizophrenia research. Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617 [TBL] [Abstract][Full Text] [Related]
15. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue. Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753 [No Abstract] [Full Text] [Related]
16. Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Lee T; Seeman P Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525 [TBL] [Abstract][Full Text] [Related]
17. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia. Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577 [TBL] [Abstract][Full Text] [Related]
18. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia. Clow A; Jenner P; Theodorou A; Marsden CD Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799 [No Abstract] [Full Text] [Related]